Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

LungVITamin D and OmegA-3 Trial [ANCILLARY OF 700049031]

Trial Profile

LungVITamin D and OmegA-3 Trial [ANCILLARY OF 700049031]

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 23 Jan 2019

At a glance

  • Drugs Colecalciferol (Primary) ; Omega-3-acid ethyl esters (Primary)
  • Indications Asthma; Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Acronyms lungVITAL
  • Most Recent Events

    • 15 Jan 2019 Planned End Date changed from 1 Oct 2017 to 1 Nov 2020.
    • 15 Jan 2019 Planned primary completion date changed from 1 Oct 2017 to 1 Nov 2020.
    • 07 Mar 2017 The trial design and patient population details published in the Contemporary Clinical Trials
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top